A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3781-3787

  Davis, Nancy L ^a   Brown, Kevin W ^a   Johnston, Robert E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; IMMUNOGENICITY; INFECTION CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS REPLICATION;

EID: 0029949803     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.3781-3787.1996     Document Type: Article

References (39)

1. Bartz, C., W. Laegreid, W. Short, N. Davis, R. Johnston, and J. Smith. Unpublished results.
2. Burke, K. L., G. Dunn, M. Ferguson, P. D. Minor, and J. W. Almond. 1988. Antigen chimaeras of poliovirus as potential new vaccines. Nature (London) 332:81-82.
3. Burke, D. S., H. H. Ramsburg, and R. Edelman. 1977. Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. J. Infect. Dis. 136:354-359.
4. Caley, I. J., N. L. Davis, D. M. Irlbeck, R. I. Swanstrom, and R. E. Johnston. Unpublished results.
5. Charles, P. C., K. W. Brown, N. L. Davis, M. K. Hart, and R. E. Johnston. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Submitted for publication.
6. Charles, P. C., E. Walters, F. Margolis, and R. E. Johnston. 1995. Mechanism of neuroinvasion of Venezuelan equine encephalitis virus in the mouse. Virology 208:662-671.
7. Davis, N. L., K. W. Brown, G. F. Greenwald, A. J. Zajac, V. L. Zacny, J. F. Smith, and R. E. Johnston. 1995. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1. Virology 212:102-110.
8. Davis, N. L., N. Powell, G. F. Greenwald, L. V. Willis, B. J. B. Johnson, J. F. Smith, and R. E. Johnston. 1991. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology 183:20-31.
9. Davis, N. L., L. V. Willis, J. F. Smith, and R. E. Johnston. 1989. In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant. Virology 171:189-204.
10. Gleiser, C. A., W. S. Gochenour, Jr., T. O. Berge, and W. D. Tigertt. 1962. The comparative pathology of experimental Venezuelan equine encephalitis infection in different animal hosts. J. Infect. Dis. 110:80-97.
11. Grieder, F. B., N. L. Davis, J. A. Aronson, P. C. Charles, D. C. Sellon, K. Suzuki, and R. E. Johnston. 1995. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins. Virology 206:994-1006.
12. Grunhaus, A., and M. S. Horwitz. 1992. Adenoviruses as cloning vectors. Semin. Virol. 3:237-252.
13. Hahn, C. S., Y. S. Hahn, T. J. Braciale, and C. M. Rice. 1992. Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc. Natl. Acad. Sci. USA 89:2679-2683.
14. Hughes, S. H., J. J. Greenhouse, C. J. Petropoulos, and P. Sutrave. 1987. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61:3004-3012.
15. Jackson, A. C., S. K. SenGupta, and J. F. Smith. 1991. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters. Vet. Pathol. 28:410-418.
16. Jahrling, P. B., and E. H. Stephenson. 1984. Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters. J. Clin. Microbiol. 19:429-431.
17. Kinney, R. M., J. J. Esposito, J. H. Mathews, B. J. B. Johnson, J. T. Roehrig, A. D. T. Barrett, and D.W. Trent. 1988. Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J. Virol. 62:4697-4702.
18. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
19. Levis, R., S. Schlesinger, and H. V. Huang. 1990. Promoter for Sindbis virus RNA-dependent subgenomic RNA transcription. J. Virol. 64:1726-1733.
20. Li, S., V. Polonis, H. Isobe, H. Zaghouani, R. Guinea, T. Moran, C. Bona, and P. Palese. 1993. Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. J. Virol. 67:6659-6666.
21. Liljtstrom, P., and H. Garoff. 1991. A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Biotechnology 9:1356-1361.
22. Liljestrom, P., S. Lusa, D. Huylebroeck, and H. Garoff. 1991. In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release. J. Virol. 65:4107-4113.
23. London, S. D., A. L. Schmaljohn, J. M. Dalrymple, and C. M. Rice. 1991. Infectious enveloped RNA virus antigenic chimeras. Proc. Natl. Acad. Sci. USA 89:207-211.
24. Lovett, A. E., C. S. Hahn, C. M. Rice, T. K. Frey, and T. S. Wolinsky. 1993. Rubella virus-specific cytotoxic T-lymphocyte responses: identification of the capsid as a target of major histocompatibility complex class I-restricted lysis and definition of two epitopes. J. Virol. 67:5849-5858.
25. Moss, B., G. L. Smith, J. L. Gerin, and R. H. Purcell. 1984. Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (London) 311:67-69.
26. Murphy, B. R. 1995. Mucosal immunity to viruses, p. 333-343. In P. L. Ogra et al. (ed.), Mucosal immunology, vol. 1: cellular basis of mucosal immunity. Academic Press, San Diego, Calif.
27. Olmsted, R. A., W. J. Meyer, and R. E. Johnston. 1986. Characterization of Sindbis virus epitopes important for penetration in cell culture and pathogenesis in animals. Virology 148:245-254.
28. 2 terminus. J. Cell Biol. 117:729-743.
29. Powers, A. M., K. E. Olson, S. Higgs, J. O. Carlson, and B. J. Beatty. 1994. Intracellular immunization of mosquito cells to LaCrosse virus using a recombinant Sindbis virus vector. Virus Res. 32:57-67.
30. Pratt, W. D., N. L. Davis, R. E. Johnston, and J. F. Smith. Unpublished results.
31. Ramphal, R., R. C. Cogliano, J. W. Shands, Jr., and P. A. Small, Jr. 1979. Serum antibody prevents lethal murine influenza pneumonitis but not tracheitis. Infect. Immun. 25:992-997.
32. Rice, C. M. (ed.). 1992. Animal virus expression vectors. Semin. Virol. 3:237-310.
33. Sanmartine, C. 1972. Diseased hosts: man, p. 186-188. In Proceedings of the Workshop Symposium on Venezuelan Encephalitis Virus 1972. Pan American Health Organization, Washington, D.C.
34. Staudt, L. M., and W. Gerhard. 1983. Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice. J. Exp. Med. 157:687-704.
35. Strauss, J. H., and E. G. Strauss. 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58:491-562.
36. Turell, M. J., N. L. Davis, R. E. Johnston, and J. F. Smith. Unpublished results.
37. Xiong, C., R. Levis, P. Shen, S. Schlesinger, C. Rice, and H. V. Huang. 1989. Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 243:1188-1191.
38. Vetter, R. A., S. Lehrer, R. Ramphal, and P. A. Small, Jr. 1980. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immun. 29:654-662.
39. Zhou, X., P. Berglund, G. Rhodes, S. E. Parker, M. Jondal, and P. Liljestrom. 1994. Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12:1510-1514.